Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

September 24, 2018

Study Completion Date

September 2, 2019

Conditions
Urologic Neoplasms
Interventions
DRUG

Afatinib

Trial Locations (30)

17007

Hospital Universitari de Girona Doctor Josep Trueta, Girona

27003

Hospital Universitario Lucus Augusti, Lugo

28034

Hospital Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital La Paz, Madrid

28050

CIO Clara Campal, Madrid

30029

INS Cancérologie du Gard, Nîmes

31059

INS Universitaire du Cancer, Toulouse

33076

INS Bergonié, Bordeaux

41009

Hospital Virgen Macarena, Seville

41013

Hospital Virgen del Rocío, Seville

46009

Instituto Valenciano de Oncología, Valencia

52100

Ospedale San Donato di Arezzo, Arezzo

69373

CTR Leon Berard, Lyon

75010

HOP Saint-Louis, Paris

75014

HOP Cochin, Paris

75015

HOP Européen G. Pompidou, Paris

92150

HOP Foch, Suresnes

94805

INS Gustave Roussy, Villejuif

00152

A.O. San Camillo Forlanini, Roma

08916

Hospital Germans Trias i Pujol, Badalona

08003

Hospital del Mar, Barcelona

08025

Hospital Santa Creu i Sant Pau, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

08038

Hospital Vall d'Hebron, Barcelona

03202

Hospital Universitario de Elche, Elche

08908

Hospital Duran i Reynals, L'Hospitalet de Llobregat

07010

Hospital Son Espases, Palma de Mallorca

08208

CS Parc Taulí, Sabadell

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY